CD4 and infection: An analysis of blood samples from critical COVID-19 patients revealed the presence of SARS-CoV-2 spike glycoprotein-specific CD4+ T cells in all patients, while 80% exhibited specific CD8+ T cells, which emerged early in the infection and increased over time87.